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We have been studying protein components that func-
tion in the cytoplasm to vacuole targeting (Cvt) pathway
and the overlapping process of macroautophagy. The
Vac8 and Apg13 proteins are required for the import of
aminopeptidase I (API) through the Cvt pathway. We
have identified a protein-protein interaction between
Vac8p and Apg13p by both two-hybrid and co-immuno-
precipitation analysis. Subcellular fractionation of API
indicates that Vac8p and Apg13p are involved in the
vesicle formation step of the Cvt pathway. Kinetic anal-
ysis of the Cvt pathway and autophagy indicates that,
although Vac8p is essential for Cvt transport, it is less
important for autophagy. In vivo phosphorylation ex-
periments demonstrate that both Vac8p and Apg13p are
phosphorylated proteins, and Apg13p phosphorylation
is regulated by changing nutrient conditions. Although
Apg13p interacts with the serine/threonine kinase
Apg1p, this protein is not required for phosphorylation
of either Vac8p or Apg13p. Subcellular fractionation ex-
periments indicate that Apg13p and a fraction of Apg1p
are membrane-associated. Vac8p and Apg13p may be
part of a larger protein complex that includes Apg1p
and additional interacting proteins. Together, these
components may form a protein complex that regulates
the conversion between Cvt transport and autophagy in
response to changing nutrient conditions.
The majority of intracellular degradation is carried out in the
lysosome/vacuole of eukaryotic cells. In order to compartmen-
talize these reactions, substrates as well as degradative en-
zymes must be faithfully delivered to this organelle. In Saccha-
romyces cerevisiae, proteins are known to be delivered to the
vacuole for degradation by several different pathways (1). For
example, cell surface proteins are transported by endocytosis;
the cytosolic enzyme fructose-1,6-bisphosphatase is targeted to
the vacuole by the vacuolar import and degradation pathway
when changing nutrient conditions necessitate down-regula-
tion; and during periods of starvation, bulk cytosol is packaged
into vesicles and delivered to the vacuole by macroautophagy.
Vacuole resident proteins are delivered by four characterized
pathways. In the carboxypeptidase Y pathway, proteins travel
through the secretory pathway and are diverted from the late
Golgi to the vacuole via an endosomal intermediate or prevacu-
olar compartment (PVC).1 The multivesicular body sorting
pathway also utilizes the PVC, but in this case proteins enter
vesicles resulting from invagination of the organelle’s limiting
membrane. The alkaline phosphatase (ALP) pathway utilizes
the early secretory compartments, but the proteins are trans-
ported from the late Golgi to the vacuole without passing
through the PVC. In the cytoplasm to vacuole targeting (Cvt)
pathway, cargo is packaged into cytosolic vesicles that are
delivered to the vacuole.
Under vegetative conditions the yeast vacuolar hydrolase
aminopeptidase I (API) is targeted to the vacuole by the Cvt
pathway. API is synthesized as a precursor in the cytosol where
it rapidly oligomerizes into dodecamers (2). Multiple API do-
decamers then assemble into a membrane-bound complex
called a Cvt complex (3). Double membrane structures sur-
round the Cvt complex resulting in the formation of Cvt vesi-
cles. The outer membrane of these vesicles fuses with the
vacuole resulting in the release of a still intact vesicle, called a
Cvt body, into the vacuole lumen. These structures are broken
down by resident hydrolases, and the released precursor API
(prAPI) is processed to its mature size.
Yeast mutants have been isolated that are defective in the
Cvt pathway (4, 5). Analysis of these mutants revealed that
many are allelic to mutants in macroautophagy (apg and aut;
Refs. 5–8). This was a surprising finding because the transport
of prAPI is selective and constitutive, while delivery of soluble
cytosolic proteins to the vacuole by macroautophagy is nonse-
lective and is induced by stress conditions such as starvation
(5). However, it is worth noting that under certain conditions
macroautophagy may be a selective process. For example, per-
oxisomes can be selectively degraded by a macroautophagic
process in response to changing nutrient conditions (reviewed
in Ref. 9).
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Biochemical and morphological studies confirm that the ba-
sic properties of targeting by the Cvt pathway are similar to
those of macroautophagy (3, 10). Both pathways involve forma-
tion of double membrane vesicles that engulf cytosolic cargo
and deliver it to the vacuole by fusion of the outer membrane
with the vacuole surface. When cells are growing in rich media,
the primary mode of prAPI delivery is via Cvt vesicles (3).
These vesicles are approximately 150 nm in diameter, rela-
tively rare, and contain concentrated cargo that appears differ-
ent than bulk cytosol. In contrast, in starvation conditions, the
majority of prAPI appears to be targeted to the vacuole by
autophagosomes. Compared with Cvt vesicles, autophago-
somes are larger (approximately 300–900 nm), more abundant,
and appear to contain bulk cytosolic components in addition to
Cvt complexes. The mechanisms by which environmental
changes are transduced to signal alterations in vesicle mor-
phology and selectivity are not known. Recent cloning of the
genes that complement mutants defective in the autophagy
and Cvt pathways indicates that the majority of the molecular
components involved in these pathways are shared (reviewed
in Ref. 9). However, several mutants have been identified that
appear to be defective primarily in one or the other of these
pathways. These include aut4 (6), apg17,2, cvt3 (5), cvt9,3 tlg2
(11), and vac8 (12).
The vac8 mutant was identified through a screen for strains
defective in vacuole inheritance (13). In addition to a role in the
migration of vacuoles from the mother to the bud during cell
division, Vac8p is required for Cvt transport. Analysis of vac8
mutants by a vesicle test that monitors the accumulation of
subvacuolar vesicles under starvation conditions, however, pro-
vided preliminary evidence that this protein is not necessary
for autophagy (12). The majority of Vac8p consists of 11 arma-
dillo repeats. These domains are contained within the Drosoph-
ila armadillo protein and the mammalian homologues b-cate-
nin and plakoglobin. The armadillo domains in b-catenin and
plakoglobin serve to link regions of the plasma membrane to
actin, and Vac8p co-sediments with actin filaments in vitro
(12). Localization experiments indicate that Vac8p is found
primarily on the vacuole membrane (12, 14, 15). In addition,
Vac8p is both myristoylated and palmitoylated, and mutational
analysis indicates that acylation is required both for vacuole
localization of Vac8p and for vacuole inheritance. Interestingly,
vac8 mutants defective in acylation are not defective in Cvt
transport, suggesting that different cellular pools of Vac8p are
utilized for inheritance and Cvt transport (12).
To identify proteins that interact with Vac8p, we have per-
formed a two-hybrid screen using this protein as bait. We
identified Apg13p as a Vac8p-interacting protein. Apg13p is
predicted to be an 83-kDa protein, with no significant homology
to other known proteins (16). Overexpression of APG1 sup-
presses the autophagy defect in the apg13–1 mutant, suggest-
ing that these two proteins also interact (16). Mutants in
APG13 are defective in both the Cvt and autophagy pathways
(5, 16). We propose that these proteins are part of a large
protein complex that functions in the vesicle formation step
that is required for sequestration of cargo during import from
the cytoplasm to the vacuole.
EXPERIMENTAL PROCEDURES
Strains and Media—The S. cerevisiae strains used in this study are
listed in Table I.
Yeast strains were grown in the indicated media: synthetic minimal
medium (SMD; 0.67% yeast nitrogen base, 2% glucose, and auxotrophic
amino acids and vitamins as needed), YPD (1% yeast extract, 2%
peptone, 2% glucose), synthetic minimal medium containing 2% glucose
without ammonium sulfate or amino acids (SD-N), and low phosphate
medium (NPM; 2% glucose, 0.5% casamino acids, 13 complete amino
acid mix, 1% proline, 2 mM NaCl, 4 mM MgCl2).
Reagents—Restriction endonucleases and DNA modifying enzymes
were from New England Biolabs (Beverly, MA). Proteinase K and
complete EDTA-free protease inhibitor mixture were from Roche Mo-
lecular Biochemicals. Antiserum to proteinase A (PrA), ALP, and Vac8p
were described previously (12, 17, 18). Antiserum to Apg13p and Cvt9p
were generated as described.2,3 Antiserum to phosphoglycerate kinase
(PGK) was generously provided by Dr. Jeremy Thorner (19). Mono-
clonal antibodies to the hemagglutinin epitope were from Covance
Research Products (Richmond, CA). Horseradish peroxidase-conjugated
anti-rabbit goat antibody was from Jackson ImmunoResearch Labora-
tories, Inc. (West Grove, PA). ECL reagents were from Amersham
Pharmacia Biotech. EXPRE35S35S protein-labeling mix and
[33P]orthophosphate were from NEN Life Science Products. Oxalyticase
was from Enzogenetics (Corvallis, OR) and Zymolyase 100T from Seika-
gaku Kogyo (Tokyo, Japan). Immobilon-P (polyvinylidene fluoride) was
from Millipore Corp. (Bedford, MA). Plasmid pTrcHisB was from In-
vitrogen (Carlsbad, CA). Antiserum to Apg1p and additional antiserum
to Apg13p were generated as follows: Synthetic peptides corresponding
to amino acids 105–123 and 643–664 of Apg1p and amino acids 613–
633 and 715–726 of Apg13p were conjugated to keyhole limpet hemo-
cyanin (Multiple Peptide Systems, San Diego, CA) and injected into
New Zealand White rabbits. All other reagents were from Sigma.
Constructs and Two-hybrid Analysis—The plasmid pCuCvt9 ex-
pressing the CVT9 gene under control of the regulable CUP1 promoter
will be described elsewhere.3 Plasmid pYK128 contains the APG1 gene
with an N-terminal 3xHA epitope tag cloned into the vector pRS423,
pYW10 contains VAC8 cloned into pRS426 (12) and YEp351(APG13)
contains the APG13 gene cloned into the YEp351 plasmid.2 The follow-
ing plasmids encode VAC8 bearing deletions in the indicated armadillo
repeat domains: pLT4, DArm1; pLT5, DArm2; pLT6, DArm3; pYWT1,
2 Y. Kamada, T. Funakoshi, T. Shintani, K. Nagano, M. Ohsumi, and
Y. Ohsumi, submitted for publication.
3 J. Kim, J. Guan, Y. Kamada, A. Hefner-Gravink, Y. Ohsumi, and
D. J. Klionsky, manuscript in preparation.
TABLE I
Yeast strains used in this study
Strain Genotype Source or reference
SEY6210 MATa leu2–3,112 ura3–52 his3-D200 trp1-D901 lys2–801 suc2-D9 GAL (41)
BJ2168 MATa prb1–1122 prc1–407 pep4–3 leu2 trp1 ura3–52 gal2 (42)
LWY7235 MATa leu2–3,112 ura3–52 his3-D200 trp1-D901 lys2–801 suc2-D9 (12)
TN121 MATa leu2–3,112 trp1 ura3–52 pho8<pho8D60 pho13<URA3 (36)
TN124 MATa leu2–3,112 trp1 ura3–52 pho8::pho8D60 pho13::LEU2 (36)
NNY20 MATa ura3 trp1 leu2 apg1D<LEU2 (28)
TVY1 MATa leu2–3,112 ura3–52 his3-D200 trp1-D901 lys2–801 suc2-D9 GAL pep4D<LEU2 (43)
AHY001 SEY6210 cvt9D<HIS3 This study
D3Y101 LWY7235 apg13D<LEU2 This study
D3Y102 SEY6210 vac8D<TRP1 This study
D3Y103 TN124 apg13D<URA3 This study
D3Y104 TN121 vac8D<TRP1 This study
D3Y105 D3Y101 pep4D<URA3 This study
D3Y106 TVY1 vac8D<TRP1 This study
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DArm4–74; and pYW51, DArm1–3 (12).
APG13 was amplified from strain SEY6210 genomic DNA into two
overlapping fragments by two PCR reactions. For reaction one, the
sense primer was 59-CGCGTCAGAGCAAGAGGTGAAAGGGTTGCCA-
CGTA-39 and the antisense primer was 59-GTGGCCCGTAGTTGGAG-
CTCATACTTGGCC-39. For reaction two, the sense primer was 59-GT-
CTATCCAATATCGAGACCTGTTCAACCA-39 and the antisense
primer was 59-GGAAACGCAGTCAGCGGGTGACAAATAAGC-39.
Utilizing the overlapping fragments as a template, the APG13 coding
region was PCR-amplified with the primers 59-GTTGAATAGCTGCAG-
TCCTGGTTGCCGAAG-39, which adds a PstI site, and 59-TAAAATAA-
AAGCTTACCATTTTTA-39, which adds a HindIII site. The amplified
fragment was inserted into the PstI and HindIII sites of pTrcHisB to
generate pTrcHisBAPG13.
Construction of the VAC8 Two-hybrid Bait Plasmid—The VAC8 cod-
ing region was PCR-amplified with the primers V22 (59-CATGCCATG-
GTGGGTTCATGTTGTAGTTGC-39), which adds a NcoI site and
V23 (59-ACGCGTCGACTCAATGTAAAAATTGTAAAATCTGTTG-39),
which adds a SalI site. NcoI-SalI-digested VAC8 was cloned into NcoI-
SalI-digested pAS2 (20) to create the VAC8 two-hybrid bait plasmid
pYW31. The same strategy was used to clone the mutated vac8 gene
from pLT4, pLT5, pLT6, pYWT1, and pYW51 into the two-hybrid
vector.
Two-hybrid Library Screen—The bait plasmid pYW31 was trans-
formed into the yeast strain PJ69-4A (21) and checked for activation of
the reporter genes. The resulting strain PJ69-4A 1 pYW31 was trans-
formed with the two-hybrid yeast library pool Y2HL-C1 (21). Approxi-
mately 280,000 transformants were screened. The transformants were
plated onto SC-His-Leu-Trp 1 3 mM 3-amino-1,2,4-triazole and incu-
bated at 24 °C for 14 days. These plates were replica plated onto
SC-Ade-Leu-Trp and incubated at 24 °C for 5 days. Colonies were
picked and tested for b-galactosidase activity. Library plasmids were
isolated from the yeast strain and retransformed into PJ69-4A 1
pYW31. Plasmids that showed positive responses after retransforma-
tion were sequenced and identified by comparison with the Saccharo-
myces Genome Data base. Two identical clones of APG13 that coded for
amino acids 567–738 were isolated.
Construction of the APG13 Two-hybrid Prey Plasmids—Plasmid
pTrcHisBAPG13 was digested with PstI and HindIII. The 2.2-kb
APG13 fragment was cloned into PstI-HindIII-cut pBlueScript SK to
create pJN21. The following plasmids were generated by digesting
pJN21 with the indicated enzymes, isolating DNA of the size noted, and
ligating into pGAD-C (1–3) that had been digested with the indicated
enzymes to construct prey plasmids encoding the indicated number of
amino acids of Apg13p: pJN22 (pADAPG13), SalI and partially digested
with BamHI (2.2 kb), into BamHI-SalI sites of C2, full-length Apg13p;
pJN23 (pAD1–520APG13), BamHI (1.6 kb), into BamHI sites of C2,
amino acids 1–520; pJN24 (pAD1–279APG13), BamHI-NsiI (0.8 kb),
into BamHI-PstI sites of C2, amino acids 1–279; pJN25 (pAD280–
520APG13), NsiI-BamHI (0.8 kb), into PstI-BglII sites of C2, amino
acids 280–520; pJN26 (pAD280–714APG13), NsiI (1.3 kb), into PstI
sites of C2, amino acids 280–714; pJN27 (pAD521–738APG13), BamHI-
SalI (0.7 kb), into BamHI-SalI sites of C3, amino acids 521–738; pJN28
(pAD521–692APG13), BamHI-ClaI (0.5 kb), into BamHI-ClaI sites of
C3, amino acids 521–692; pJN29 (pAD693–738APG13), ClaI-SalI (0.2
kb), into ClaI-SalI sites of C1, amino acids 692–738.
Control plasmids for the two-hybrid analysis were pSE1111 contain-
ing SNF4 fused to the GAL4 activation domain in pACT and pSE1112
containing SNF1 fused to the GAL4 binding domain in pAS1 (22).
Subcellular Fractionation—Yeast strains were grown to an A600 5
0.8–1, and converted to spheroplasts as described (23). vac8D cells were
grown in SMD, and apg13D cells were grown in YPD. Spheroplasts were
washed in PS1000 (20 mM K-PIPES, pH 6.8, 1 M sorbitol), and subjected
to osmotic lysis (23) by pipetting up and down 10 times in PS200 with
MgCl2 (20 mM K-PIPES, pH 6.8, 200 mM sorbitol, 5 mM MgCl2) at a cell
concentration of 20 A600/ml. The supernatant and pellet fractions were
collected after centrifugation at 5000 3 g for 5 min. A flotation analysis
was carried out as described previously (23). The pellet fraction was
resuspended in 100 ml of 15% Ficoll, and then overlaid with 1 ml of 13%
Ficoll and 300 ml of 2% Ficoll. The resulting step gradients were sub-
jected to centrifugation in a microcentrifuge at 12,000 3 g for 10 min.
The float fraction was collected from the 2% Ficoll/13% Ficoll interface.
Proteinase K treatment was with 50 mg of proteinase K for 15 min on ice
with a concentration of osmotically lysed spheroplasts equivalent to 20
A600/ml. All fractions were precipitated with trichloroacetic acid, re-
solved by SDS-polyacrylamide gel electrophoresis, and subjected to
immunoblotting as described (4).
Fractionation of Apg13p and Apg1p was as above except that the
isolated spheroplasts were washed with PS1000 with complete EDTA-
free protease inhibitor mixture before lysis and then lysed in PS200
with 5 mM MgCl2 and protease inhibitors. The pellet fraction was
collected by centrifugation at 13,000 3 g for 5 min at 4 °C.
Pulse-Chase Labeling Analysis—Pulse labeling experiments were as
described (5). Yeast strains were grown in SMD medium to an A600 5
0.8–1, pelleted, and then pulse-labeled at 30 °C in fresh SMD with 11
mCi/A600 Expre
35S35S label. Chase reactions were initiated by addition
of 10 mM cysteine and 20 mM methionine. Cells were then pelleted and
resuspended at a concentration of 1 A600/ml in either SMD or SD-N for
the duration of the chase reaction. API was immunoprecipitated as
described (24).
Electron Microscopy—Indicated yeast strains were grown in YPD to
an A600 5 1, harvested, washed, incubated in SD-N for 4 h, and fixed
with 1.5% KMnO4 as described (25).
Phosphate Labeling—Cells were grown to an A600 of 0.5–1 in NPM. 4
A600 units of cells were harvested and labeled for 30 min at 30 °C in 100
ml of fresh NPM with 25 mCi of [33P]orthophosphate. Cells were recov-
ered by centrifugation, and proteins were precipitated with 10% trichlo-
roacetic acid and subjected to immunoprecipitation as described previ-
ously (24), except that single precipitation reactions were performed.
Co-immunoprecipitation Experiments—BJ2168 cells harboring
pYW10 and YEp351(APG13) were grown in 100 ml of YPD, collected by
centrifugation, washed with water, and resuspended in 50 ml of Z buffer
(50 mM Tris-HCl pH7.5, 1 M sorbitol, 1% yeast extract, 2% peptone, 1%
glucose) containing 0.5 mg/ml Zymolyase 100T. The suspension was
incubated for 40 min at 30 °C with gentle shaking to generate sphero-
plasts. The resultant spheroplasts were washed once with Z buffer,
resuspended in 50 ml of Z buffer, and divided into two 25-ml aliquots.
Rapamycin (0.4 mg/ml, prepared in 90% ethanol, 10% Triton X-100) was
added to one aliquot, and the spheroplasts were incubated for 1 h at
30 °C with gentle shaking. The spheroplasts were collected and washed
with 50 mM Tris-HCl, pH 7.5, 1 M sorbitol, and lysed by suspending in
1 ml of lysis buffer (phosphate-buffered saline, pH 7.4, 1 mM EDTA, 1
mM EGTA, 2 mM Na3VO4, 50 mM KF, 15 mM sodium pyrophosphate, 15
mM p-nitrophenylphosphate, 20 mg/ml leupeptin, 20 mg/ml benzami-
dine, 10 mg/ml pepstatin A, 40 mg/ml aprotinin, 1 mM phenylmethylsul-
fonyl fluoride, and 0.5% Tween 20). The cell lysate was further incu-
bated on ice for 5 min, and spun down at 6,500 rpm for 10 min at 4 °C
to remove cell debris. The resultant supernatant was collected and
incubated with 20 ml of protein G-Sepharose (50% suspension) for 30
min at 4 °C with gentle agitation. The cell lysate was spun down, and
the supernatant (two 500-ml aliquots) was incubated with or without 2
ml of anti-Vac8p serum for 1.5 h at 4 °C with gentle agitation. 20 ml of
protein G-Sepharose (50% suspension) was added to the lysate/anti-
serum mixture, followed by further incubation for 1.5 h at 4 °C with
gentle agitation. The immune complex was washed three times with
lysis buffer, and the resulting immunocomplex was subjected to immu-
noblotting using anti-Apg13p antibody (1:5,000 dilution) or anti-Vac8p
antibody (1:5,000 dilution). For secondary antibody, horseradish perox-
idase-conjugated anti-rabbit goat antibody (1:10,000) was used. Immu-
nodetection was carried out with the ECL system.
RESULTS
Vac8p and Apg13p Interact—The vac8 mutant was identified
in a screen for strains defective in vacuolar inheritance (13).
Vac8p is unusual among those proteins involved in organelle
segregation in that it was also found to be required for the
import of the resident vacuolar hydrolase aminopeptidase I
through the cytoplasm to vacuole targeting pathway. To gain
further information on the role of Vac8p in the Cvt pathway, a
two-hybrid screen was used to identify proteins that interact
with Vac8p. The VAC8 gene was cloned into a two-hybrid
vector containing a DNA-binding domain. A his3 ade2 strain
was transformed with the resulting pBD-VAC8 plasmid and a
plasmid library that had been cloned into the transcriptional
activating domain vector. Transformants were screened for
growth on His-free plates, and then growth on Ade-free plates
and finally for b-galactosidase activity. Plasmids were recov-
ered from cells that were positive by all three criteria and were
subjected to DNA sequencing. One of the genes that was iden-
4 F. Tang, J. Nau, E. Kauffman, and L. Weisman, manuscript in
preparation.
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tified from the screen was found to contain part of the open
reading frame corresponding to APG13 (Fig. 1A). The APG13
gene was identified as being required for macroautophagy (16)
and was subsequently shown to be needed for import of prAPI
(5).
To determine the domain of Apg13p that interacts with
Vac8p, a series of deletions was constructed in the APG13 gene
that was used as the prey plasmid for the two-hybrid interac-
tion. APG13 constructs lacking the sequence for the C-terminal
46 amino acids showed a dramatically reduced interaction with
a full-length VAC8 bait plasmid (Fig. 1B). Conversely, an
APG13 prey construct encoding only the C-terminal 46 amino
acids of Apg13p also was unable to promote interactions with
Vac8p. These results suggest that the C terminus of Apg13p,
including but possibly extending beyond the final 46 amino
acids, is required for the interaction. However, additional data
suggest that more than one domain of Apg13p may be involved
in the interaction with Vac8p. Apg13p lacking amino acids 568
to 738 is able to partially complement the prAPI import defect
of an apg13D strain.2 The truncated Apg13 protein does not
function as efficiently as full-length Apg13p, suggesting that
the absence of the interaction domain causes a kinetic defect in
prAPI import.
The bulk of the structure of Vac8p consists of 11 consecutive
armadillo (Arm) repeats, each of 40–42 amino acids in length.
These domains are thought to mediate protein-protein interac-
tions (26). To determine if the interaction of Vac8p and Apg13p
depends on the presence of Arm repeats within Vac8p, we
tested the effect of deleting various Vac8p Arm domains by
two-hybrid analysis. We found that, with the exception of Arm
1, all the Arm repeats examined were required for detection of
the Vac8p-Apg13p interaction by the two-hybrid method (Fig.
1C). All of these Vac8p Arm deletion constructs produce stable
proteins in yeast (data not shown). Next, we examined the
effect of the Arm deletions on transport of prAPI. By immuno-
blot analysis, with the exception of the Arm 1 deletion, prAPI
accumulated in cells where the only Vac8p present contained
an Arm deletion (Fig. 1D). The fact that mutations that appear
to prevent interaction of Vac8p and Apg13p also inhibit Cvt
transport suggests that the Arm domains are important for
Vac8p function. Furthermore, these results suggest that the
interaction between Vac8p and Apg13p is needed for efficient
import of prAPI through the Cvt pathway.
To verify that the native Vac8 and Apg13 proteins interact in
vivo, we performed a co-immunoprecipitation analysis. Protein
extracts were prepared from yeast cells under native conditions
and immunoprecipitated with antiserum to Vac8p. The immu-
noprecipitates were resolved by SDS-polyacrylamide gel elec-
trophoresis, transferred to polyvinylidene fluoride membrane,
and Apg13p was detected by immunoblot using anti-Apg13p
FIG. 1. Two-hybrid interaction
identifies Apg13p as a protein that
interacts with Vac8p. A, growth on SC-
Ade-His-Trp-Leu 1 3 mM 3-amino-1,2,4-
triazole after 5 days at 24 °C. Plasmids
transformed into PJ69-4A (WT) and the
corresponding apg1D strains are indi-
cated. Vac8p interacts with full-length
Apg13p in both wild type and apg1D
strains. B, growth on SC-Ade-His-Trp-
Leu 1 3 mM 3-amino-1,2,4-triazole.
PJ69-4A was transformed with pYW31
(VAC8) and the APG13 constructs indi-
cated. Numbers indicate the amino acids
of Apg13p. 1 indicates growth after 5
days at 24 °C. 0 indicates no growth after
5 days at 24 °C. 1/2 indicates slight
growth after 12 days at 24 °C. C, Arm
domains in Vac8p are required for
Apg13p interaction. Strain PJ69-4A was
transformed with pAD521–738APG13
and binding domain plasmids containing
either wild type VAC8 (WT), or arm dele-
tions of VAC8 as indicated. 1 indicates
growth after 5 days at 24 °C. 0 indicates
no growth after 5 days at 24 °C. D, Arm
domains in Vac8p are required for Cvt
transport. vac8D cells were transformed
with plasmids containing either wild type
VAC8 (WT) or the indicated arm deletions
of VAC8. Cells were grown overnight in
SMD, and API was examined by
immunoblot.
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antiserum as described under “Experimental Procedures.”
When the immunoprecipitation was carried out in a strain
overexpressing VAC8, but with a deletion in the chromosomal
APG13 locus, only Vac8p was detected on the immunoblot,
indicating that there were no background bands that migrated
at the position of Apg13p (Fig. 2, lane 1). Similarly, in the
absence of antiserum to Vac8p, neither protein was detected on
the immunoblot, indicating that they did not bind nonspecifi-
cally to the protein G-Sepharose beads (Fig. 2, lanes 2, 4, and
6). In contrast, Apg13p was found to co-immunoprecipitate
with anti-Vac8p antiserum when both Vac8p and Apg13p were
expressed from multicopy plasmids (Fig. 2, lane 3). This result
confirms that Vac8p and Apg13p interact in vivo. The drug
rapamycin mimics starvation conditions and induces autoph-
agy by inhibiting the Tor kinase (27). Apg13p and Vac8p were
found to interact in vivo following treatment with rapamycin
(Fig. 2, lane 5). Similarly, Vac8p and Apg13p were found to
interact under starvation conditions based on the two-hybrid
analysis (data not shown). These results mean that Vac8p and
Apg13p interact under both vegetative conditions where the
Cvt pathway functions and starvation conditions that induce
autophagy.
Both genetic and biochemical data indicate that Apg13p
interacts with another protein required for both the Cvt path-
way and autophagy, the serine/threonine kinase Apg1p (16,
28),2 In addition, recent two-hybrid results showing that
Apg13p and Apg1p interact corroborate these findings (29).
The Vac8p/Apg13p interaction was not dependent on the pres-
ence of Apg1p because similar two-hybrid results were ob-
tained in an apg1D strain (Fig. 1A). These result suggest that
Vac8p and Apg13p interact independent of Apg1p.
Strains with Mutations in VAC8 and APG13 Are Defective in
the Membrane Enwrapping Step of the Cvt Pathway—Biochem-
ical localization of prAPI has been used to determine the step of
the Cvt pathway that is blocked in various apg and cvt mutants
(10). Mutants that are blocked in vesicle formation accumulate
Cvt complexes, indicated by the appearance of prAPI in a low
speed pellet fraction. Flotation analyses demonstrate whether
the Cvt complex is associated with membrane. Protease pro-
tection assays distinguish between prAPI trapped in a Cvt
complex that is not fully surrounded by membrane and is
therefore protease-accessible in permeabilized cells, and prAPI
trapped in Cvt vesicles that appears protease-protected. Fur-
ther biochemical fractionation of mutants that accumulate pro-
tease-protected prAPI demonstrates whether prAPI is con-
tained within cytosolic vesicles (Cvt vesicles) or subvacuolar
vesicles (Cvt bodies). By these analyses, Apg5p, Apg7p, Apg9p,
and Aut7p have been shown to affect Cvt vesicle formation/
completion (30–33); Vam3p, Ypt7p, and Vps18p are required
for Cvt vesicle fusion (10, 31, 34); and Cvt17p is required for the
breakdown of Cvt bodies within the vacuole (10).
We examined the state of prAPI to determine the step of the
Cvt pathway that is blocked in the vac8 and apg13 mutants.
Spheroplasts isolated from either vac8D or apg13D strains were
subjected to differential osmotic lysis under conditions that
have been shown to efficiently lyse the plasma membrane while
preserving the integrity of most vacuoles (4, 23, 35). These
permeabilized spheroplasts were then separated into pellet and
supernatant fractions by centrifugation at 5000 3 g. In both
mutant strains, the majority of prAPI was found in the pellet
fraction (Fig. 3, A and B). We examined the localization of the
vacuolar hydrolase PrA and the cytosolic protein PGK in the
same samples as controls for the fractionation. The majority of
PGK was recovered in the supernatant fraction, while PrA was
found in the pellet fraction, indicating that the fractionation
was successful (Fig. 3, A and B).
To determine if the prAPI recovered in the pellet fraction
was in fact associated with membrane components, we per-
formed a flotation analysis using the pellet fraction as the
starting material. The prAPI trapped in both the vac8D and
apg13D strains floated through a Ficoll gradient in the absence,
but not in the presence, of detergent, suggesting that this
population of prAPI is membrane-associated. It is possible that
flotation of prAPI under these conditions reflects binding to
lipid rather than a membrane bilayer. However, in an apg5ts
mutant we were able to verify through electron microscopy that
flotation of prAPI corresponded with membrane association
(30). When permeabilized cells from the vac8D and apg13D
strains were examined by protease treatment, the majority of
prAPI was accessible to added protease in both the presence
FIG. 2. Biochemical interaction between Vac8p and Apg13p.
Cells overexpressing Vac8p were subjected to native immunoprecipita-
tion with or without anti-Vac8p antiserum as described under “Exper-
imental Procedures.” The immunoprecipitated sample was then sub-
jected to immunoblotting with antiserum against Apg13p and Vac8p.
Cells contained overexpressed Apg13p (pAPG13) as indicated. Addition
of rapamycin (Rap.) to the cultures is indicated.
FIG. 3. Precursor API in vac8D and apg13D strains is mem-
brane-associated but not enclosed within completed vesicles.
Isolated spheroplasts from either the vac8D strain (D3Y102) A, or the
apg13D strain (D3Y101) B, were osmotically lysed and the total fraction
(T) was separated into a supernatant (S) and pellet (P) fraction by
centrifugation. The resulting fractions were subjected to immunoblot-
ting with antiserum against API, PrA (a vacuole lumenal marker), or
PGK (a cytosolic marker). The pellet fraction was further analyzed by
flotation through Ficoll step gradients, resulting in the float (F) frac-
tion. 1% Triton X-100 was either added to (1) or omitted from (2) the
pellet fraction before separation on the gradient. The lysed total frac-
tion was subjected to proteinase K treatment (PK) either in the absence
(2), or presence (1) of 0.2% Triton X-100 as described under “Experi-
mental Procedures.” The positions of precursor (pr) and mature (m) API
are indicated. Note that prAPI is digested to the mature size by pro-
teinase K.
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and absence of detergent (Fig. 3, A and B). Because the vacu-
olar hydrolase PrA is primarily recovered in the pellet fraction,
intracellular compartments such as vacuoles (which are one of
the most osmotically labile subcellular compartments) are in-
tact in these samples. These results suggest that prAPI is
localized in a membrane-associated Cvt complex, and that
Vac8p and Apg13p are required for formation of the fully mem-
brane enclosed Cvt vesicle.
Vac8p Is Not Essential for Autophagy—We have reported
previously that autophagic bodies are detected in vac8D cells by
light microscopy, and thus Vac8p appeared not to be required
for autophagy (12). Because the majority of molecular compo-
nents are shared between the Cvt and autophagy pathways, we
further investigated the role of Vac8p in autophagy. Precursor
API is transported by the Cvt pathway in nutrient-rich condi-
tions and by the autophagy pathway in starvation conditions
(3, 5). Accordingly, we examined the kinetics of prAPI matura-
tion in different nutritional conditions as a biochemical method
of examining the autophagy defect in the vac8D and apg13D
strains. In wild type cells, prAPI is matured with a half-time
of about 30 min in both SMD and SD-N media (Fig. 4A). In
contrast, in an apg1D strain, no mature API is detected in
either nutrient condition. In apg13D cells, API maturation is
essentially completely blocked in YPD medium (data not
shown). In contrast, some mature API is detected after a
90-min chase in SMD medium. When these cells are chased in
SD-N, about 70% of API is mature at the 90-min chase point
(Fig. 4B). In vac8D cells, prAPI delivery is negligible in nitro-
gen-containing medium, and restored to near wild type levels
in starvation medium. These results suggest that prAPI can be
efficiently transported by autophagy in vac8D cells during star-
vation, and that Vac8p has a more central role in the Cvt
pathway than in the autophagy pathway. Furthermore, the
defect in prAPI import in the apg13D strain can be partially
overcome under starvation conditions.
To examine the kinetics of autophagy in these mutants di-
rectly, we utilized an alkaline phosphatase construct that was
designed as a marker for the autophagy pathway (36). This
protein, called Pho8D60p, consists of alkaline phosphatase in
which the membrane-spanning region and the vacuole target-
ing information have been deleted (18, 37). The resulting cyto-
solic protein is only delivered to the vacuole when autophagy is
induced. Pho8D60p still contains a site for cleavage of the
C-terminal propeptide by the vacuole hydrolase proteinase B.
Therefore, vacuolar delivery of Pho8D60p results in cleavage to
a lower molecular weight species, and activation of enzyme
activity. A pulse-chase experiment was performed to compare
the kinetics of the autophagic uptake of Pho8D60p in wild type,
vac8D, and apg13D cells (Fig. 4C). In wild type cells, matura-
tion of Pho8D60p proceeds rapidly to about the 8-h chase point
and then plateaus at about 18% delivery. In contrast, the
apg13D strain matures only a very low level of Pho8D60p,
consistent with its classification as an autophagy mutant. In
vac8D cells, an intermediate level of Pho8D60p maturation was
observed, suggesting that the autophagy pathway is active but
is not as efficient as in wild type cells.
To confirm that the autophagy pathway is carried out in
vac8D cells, we examined these cells directly by electron mi-
croscopy. Autophagy results in the delivery of an intact vesicle
called an autophagic body to the vacuole lumen. In cells defi-
cient in PrA, these vesicles cannot be broken down and accu-
mulate in starvation conditions (38). We examined the effect of
the vac8 and apg13 deletions on vesicle accumulation in cells in
which PEP4, the gene encoding PrA, had been deleted. In
pep4D cells after incubation in starvation conditions for 4 h,
numerous autophagic bodies were detected in the vacuole (Fig.
5A). In the apg13D pep4D double mutant, the vacuoles ap-
peared empty as expected, confirming a block in autophagy
resulting from the apg13 mutation (Fig. 5B). In contrast, in the
vac8D pep4D double mutant, autophagic bodies appeared to be
as abundant as in the pep4D cells (Fig. 5, compare A to C). Cells
lacking Vac8p have been shown to have fragmented vacuoles
(12). This was apparent in many of our images, which con-
tained multilobed or vesiculated vacuoles containing subvacu-
olar vesicles (data not shown). These results confirm that au-
tophagy proceeds in the vac8D strain.
Vac8p Is a Phosphoprotein—Apg13p is a phosphoprotein
that interacts with Apg1p.2 Although Apg1p is both a phospho-
protein and a protein kinase (28), the phosphorylation of
Apg13p does not appear to depend on Apg1p (Fig. 6C). To
determine if Vac8p is also a phosphoprotein, cells were meta-
FIG. 4. Kinetics of transport by the Cvt and autophagy path-
ways in vac8D and apg13D cells. A, cells from the indicated strains
(WT, TN121; apg13D, D3Y103; vac8D, D3Y104; apg1D, NNY20) were
metabolically labeled for 10 min as described under “Experimental
Procedures.” After labeling, the cells were reisolated and resuspended
in either SMD or SD-N and chased for the indicated times (min). API
was recovered by immunoprecipitation. Note that the band running
slightly below the position of mature API in the apg1D strain is a
background band. The positions of precursor (pr) and mature (m) API
are indicated. B, quantitation of the 90-min time point of the samples in
A are depicted. The black bars represent the SMD chase, and the white
bars the SD-N chase. The amount of mature API in the apg1D strain in
either condition was less than 1%. C, kinetics of Pho8D60p delivery.
Cells (wild type, TN121; vac8D, D3Y104; apg13D, D3Y103) were meta-
bolically labeled for 10 min in nitrogen-containing medium, washed,
and chased for the indicated times in SD-N. Pho8D60p was recovered by
immunoprecipitation with anti-ALP antiserum, resolved by SDS-poly-
acrylamide gel electrophoresis, and quantified using a STORM Phos-
phorImager (Molecular Dynamics, Sunnyvale, CA).
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bolically labeled with [33P]orthophosphate, and Vac8p was re-
covered by immunoprecipitation. Labeled Vac8p was recovered
from cell lysates (Fig. 6A), indicating that it is a phosphopro-
tein. In addition, the level of Vac8p phosphorylation was not
changed in an apg1D strain, suggesting that Apg1p is not the
kinase responsible for Vac8p phosphorylation. Apg1p also in-
teracts with Cvt9p.3 Like Vac8p, Cvt9p appears to play a more
predominant role in Cvt transport than in the autophagy path-
way. To determine if Cvt9p is phosphorylated, cells were again
subjected to metabolic labeling with [33P]orthophosphate, and
Cvt9p was recovered by immunoprecipitation. As is the case for
Apg13p and Vac8p, Cvt9p is a phosphoprotein that does not
appear to depend on Apg1p for phosphorylation, despite the
fact that Apg1p and Cvt9p form a complex.
The level of Apg13p phosphorylation is dependent on nutri-
tional conditions.2 The protein is hyperphosphorylated in rich
media and undergoes partial dephosphorylation in starvation
conditions. Because phosphate starvation conditions were re-
quired to get incorporation of labeled phosphate for these ex-
periments, it was not possible to compare the level of phospho-
rylation in starvation and non-starvation conditions by the
labeling method. However, Apg13p hyperphosphorylation re-
sults in a shift in relative mobility that we could detect by
SDS-polyacrylamide gel electrophoresis and immunoblot. For
these experiments, cells were grown in rich medium and then
shifted to SD-N at time 0. Upon shifting to nitrogen starvation
conditions, Apg13p was rapidly dephosphorylated as indicated
by the presence of a lower molecular weight immunoreactive
band (Fig. 6B). In contrast, the migration of Apg1p is not
affected by the change in available nitrogen. Because migration
of Apg1p is not affected by nutrient conditions, it is not possible
to use this method to determine if the level of Apg1p phospho-
rylation is nitrogen-dependent.
We also examined other mutant strains for effects on regu-
lation of Apg13p phosphorylation. Although most of the mutant
strains we examined including cvt9D and apg1D did not alter
the starvation induced dephosphorylation of Apg13p, we did
detect a change in the phosphorylation pattern of Apg13p in
vac8D cells (Fig. 6C). In wild type cells, the majority of Apg13p
was present in a high molecular weight form when the cells
were grown in rich media. In contrast, in vac8D cells, only
about 50% of Apg13p existed in the hyperphosphorylated state
in these conditions. These results suggest that hyperphospho-
rylation of Apg13p in rich media is impaired in the absence of
Vac8p.
Apg13p and Apg1p Are Membrane-associated—Vac8p is as-
sociated with the vacuole membrane (12, 14, 15). To determine
if Apg13p and Apg1p are also membrane-associated proteins,
subcellular fractionation experiments were performed. Both
Apg13p and Apg1p are expressed at low levels in the cell and
are labile in cell lysates. In order to detect these proteins in
subcellular fractionation experiments, overexpression of these
proteins was necessary, and even with the addition of protease
inhibitors, it was not possible to perform prolonged fraction-
ation procedures. Spheroplasts prepared from cells overex-
pressing either Apg13p or Apg1p were lysed osmotically and
separated into supernatant and pellet fractions. After centrif-
ugation at 13,000 3 g, Apg13p was recovered completely in the
pellet fraction (Fig. 7A). As expected, Vac8p was also recovered
in the pellet fraction, while the cytosolic marker PGK was
recovered in the supernatant fraction, confirming that mem-
brane and soluble proteins are effectively separated in this
FIG. 5. Electron microscopy of vac8D and apg13D cells reveals
that vac8D cells are competent for autophagy. A–C, TVY1 (A;
pep4D ), D3Y105 (B; apg13D pep4D), and D3Y106 (C; pep4D vac8D) cells
were grown to log phase in YPD and then shifted to SD-N for 4 h before
fixation with potassium permanganate. Electron microscopy was car-
ried out as described under “Experimental Procedures.” N, nucleus; V,
vacuole; bar, 1 mm.
FIG. 6. A, Vac8p, Apg13p, and Cvt9p are phosphoproteins. Cells from
the indicated strains (wild type (WT), SEY6210; vac8D, D3Y102; apg1D,
NNY20; cvt9D, AHY001; apg13D, D3Y101) were labeled with either 35S
or 33P and subjected to immunoprecipitation with the indicated anti-
sera. Vac8p was expressed from the chromosomal locus, and Cvt9p and
Apg13p were overexpressed. B, Apg13p is hyperphosphorylated in rich
media. Cells deleted for either APG13 (D3Y101) or APG1 (NNY20)
containing either overexpressed Apg13p or Apg1p, respectively, were
grown in SMD and then shifted to SD-N at time 0. Samples were
collected at the indicated time points, and Apg1p and Apg13p detected
by immunoblotting. C, hyperphosphorylation of Apg13p is defective in
vac8D cells. Apg13p was overexpressed in the indicated strains
(apg13D, D3Y101; apg1D, NNY20; vac8D, D3Y102; cvt9D, AHY001).
The cultures were grown in SMD and shifted to SD-N for either 0 or 30
min. Apg13p was detected by immunoblot.
Apg13p and Vac8p Form a Protein Complex25846
 at University of G









experiment. Apg13p is predicted to be a soluble protein based
on sequence analysis. To determine if its membrane localiza-
tion is mediated through Vac8p, Apg13p fractionation was also
examined in vac8D cells. As in wild type cells, Apg13p was
recovered in the pellet fraction in vac8D cells, indicating it does
not depend on its interaction with Vac8p for membrane local-
ization (Fig. 7B). In contrast to these results, a GFP-Apg13p
fusion protein displayed a diffuse cytosolic localization (data
not shown). Although this fusion protein complemented the
prAPI accumulation phenotype of the apg13D strain, it is pos-
sible that it has an altered subcellular distribution due to steric
interference by GFP.
Apg1p is also predicted to be a soluble protein based on its
deduced amino acid sequence. However, when the subcellular
distribution was examined, about 50% of Apg1p was recovered
in the 13,000 3 g pellet fraction (Fig. 7C). As before, Vac8p and
PGK were recovered primarily in the pellet and supernatant
fractions, respectively. When the 13,000 3 g supernatant frac-
tion from these experiments was subjected to centrifugation at
100,000 3 g, Apg1p remained in the supernatant fraction (data
not shown). Because some Apg1p was degraded in this longer
experiment, we cannot rule out the possibility that a fraction of
Apg1p may be in the 100,000 3 g pellet fraction. However, it
appears that the bulk of Apg1p is distributed between a
13,000 3 g pellet fraction and a soluble pool.
Because both Apg13p and Apg1p are required for autophagy,
and these proteins are thought to form a more stable complex
in starvation conditions,2 localization of these proteins was also
examined after incubation for 4 h in SD-N medium. This treat-
ment did not affect the localization of either protein. Apg13p
was still recovered in the 13,000 3 g pellet fraction, and Apg1p
was distributed between the supernatant and pellet fractions
(data not shown).
DISCUSSION
Vac8p is required for vacuole inheritance and Cvt transport.
Vac8p contains 11 armadillo (Arm) repeats. This structural
domain has been found in a number of proteins with diverse
functions and may serve as a scaffold for protein-protein inter-
actions (26). Two-hybrid analysis and co-immunoprecipitation
experiments demonstrate that Vac8p and Apg13p physically
interact with each other, and this interaction appears to be
mediated through Arm domains in Vac8p (Figs. 1 and 2). A
C-terminal domain of Apg13p in the context of a two-hybrid
protein was shown to be required for interaction with a corre-
sponding Vac8p two-hybrid construct. Surprisingly, deletion of
this domain in native Apg13p still allowed the truncated pro-
tein to partially complement the Cvt pathway defect in an
apg13D strain. One explanation may be the presence of addi-
tional sites in Apg13p that allow interaction with Vac8p. These
sites may not be functional in the context of the two-hybrid
protein. A similar situation may be seen with the GFP-Apg13p
hybrid protein that displays a subcellular distribution distinct
from that of the native Apg13 protein, i.e. fusions to Apg13p
may in some cases interfere with its ability to interact with
other proteins. Both native Vac8p and Apg13p are membrane-
associated. For Apg13p, membrane binding is independent of
Vac8p (Fig. 7). The ability to bind the target membrane may
allow the truncated Apg13p to interact inefficiently with Vac8p
due to a close proximity even in the absence of the C-terminal
Vac8p-binding domain. Alternatively, it is possible that the
truncated Apg13p does not bind Vac8p but is able to function in
the Cvt pathway through its interaction with other compo-
nents. Subcellular fractionation experiments demonstrate that
prAPI, the only known cargo of the Cvt pathway, is trapped in
a membrane-bound, protease-accessible state in both the vac8D
and apg13D strains, suggesting that both proteins are required
for the formation/completion of Cvt vesicles (Fig. 3).
Vac8p has several cellular roles and appears to be an abun-
dant protein compared with other identified autophagy compo-
nents. Other Arm proteins such as b-catenin/armadillo also
exert multiple functions through interaction with different
binding partners. The crystal structure of b-catenin has been
solved (39). The Arm repeats form a single rod-like structure
with a hydrophobic core. Each Arm domain folds into three
a-helical segments connected by short spacers. These helices
are then packed into a superhelical structure with a positively
charged groove that is thought to form a surface for interaction
with other proteins.
Vac8p is primarily located on the vacuole and requires acy-
lation for both correct localization and its role in vacuole inher-
itance (12). The fact that Vac8p acylation is not required for
Cvt transport suggests that a different subset of the Vac8p
population may be utilized for Cvt transport (12). This popula-
tion of Vac8p is likely to be in a complex with Apg13p and
bound to a membrane fraction that may or may not be the
vacuole. In addition, other components such as Cvt9p that may
interact, perhaps indirectly, with Vac8p appear to be located in
proximity to the vacuole.3 Given the protease-sensitive, mem-
brane-associated phenotype of prAPI in the vac8 null strain, it
is also possible that Vac8p associates with the Cvt vesicle and
is required for a fusion step that results in vesicle completion.
Vac8p and Apg13p are part of the same protein complex that
includes Apg1p and Cvt9p.3 However, the respective mutant
strains display somewhat different phenotypes (Figs. 4 and 5).
The apg1D strain is completely blocked in autophagy and
prAPI import in rich media or starvation conditions. In syn-
thetic minimal medium containing nitrogen, apg13D cells
slowly mature prAPI and the level of import is increased in
medium lacking nitrogen. However, the apg13D strain is defec-
tive for autophagy, as assessed both morphologically and by
maturation of Pho8D60p. The vac8D strain is completely
blocked for prAPI import in YPD or SMD. In contrast, in SD-N
this strain shows import kinetics that only slightly lag behind
those of the wild type strain. Similarly, the vac8D cells appear
to carry out autophagy in SD-N medium although at a substan-
tially reduced rate.
One explanation for these results is that Vac8p is specific to
the Cvt pathway. Accordingly, the induction of autophagy al-
lows efficient import of prAPI in the vac8D strain. The partial
defect in autophagy seen in the vac8D strain could be an indi-
rect effect of the null mutation or might be due to an alteration
in the state of the interacting protein Apg13p. It is also possible
that Vac8p plays a role in autophagosome formation but is not
essential for this process so that vac8D cells display only a
kinetic defect in autophagy. The apg13D cells may carry out
autophagy at a level that is too low to detect based on delivery
of Pho8D60p or electron microscopy. However, this level of
autophagy may be sufficient to account for the selective import
FIG. 7. Apg13p and Apg1p are localized to a pellet fraction.
Wild type (SEY6210) (A and C) or vac8D (D3Y102) cells (B) containing
overexpressed Apg13p (A and B) or overexpressed Apg1p (C) were
subjected to osmotic lysis in PS200 with MgCl2 and protease inhibitors.
The total (T), supernatant (S), and 13,000 3 g pellet (P) fractions were
collected. The indicated proteins were detected by immunoblot.
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of prAPI observed in our experiments. An alternative explana-
tion is afforded by the observation that the apg13 mutant is
leaky for the Cvt pathway in nitrogen-containing SMD me-
dium. This mutant may carry out transport of prAPI through
the formation of Cvt vesicles during both vegetative and star-
vation conditions. Because Cvt vesicles are of comparatively
low abundance, they may not have been detected by our elec-
tron microscopy analysis. Finally, it is possible that Apg13p is
required for both pathways but like Vac8p it can be bypassed.
For example, overexpression of Apg1p suppresses the apg13–1
mutation (16).
Vac8p and Apg13p, the Apg13p-interacting protein Apg1p,
and the Apg1p-interacting protein Cvt9p are phosphorylated in
vivo (Fig. 6). Apg13p and Cvt9p are thought to interact directly
with Apg1p, which is proposed to be a protein kinase. However,
these proteins are phosphorylated in apg1D cells, suggesting
that another kinase is involved. Apg13p is hyperphosphory-
lated in rich media conditions; when cells are shifted to a poor
nitrogen source, it is rapidly dephosphorylated (Fig. 6B). This
nutrient-dependent change in the level of Apg13p phosphoryl-
ation could signal the change from transport via the Cvt path-
way to the macroautophagy pathway. Hyperphosphorylation of
Apg13p is reduced in vac8D cells (Fig. 6C), suggesting that the
Vac8p/Apg13p complex may be a better substrate for phospho-
rylation than Apg13p alone and that Vac8p may help regulate
Apg13p hyperphosphorylation.
Both Apg13p and Apg1p are predicted to be soluble proteins
based on sequence analysis. In addition, a fusion protein where
the first 32 amino acids of Apg1p/Aut3p were replaced with
GFP appeared to be cytosolic (40). However, because this pro-
tein did not complement the autophagy defect in apg1D cells, it
may not represent the localization pattern of authentic Apg1p.
Similarly, a GFP-Apg13p fusion protein displayed a cytosolic
fluorescence pattern, although in this case the protein was
functional in the Cvt pathway (data not shown). Our fraction-
ation experiments examining the native proteins expressed
from multicopy plasmids indicate that Apg13p is localized in
the P13 fraction, while Apg1p is distributed between a soluble
fraction and the P13 fraction (Fig. 7). Both Apg1p and Apg13p
are unstable during subcellular fractionation procedures and
are present at low levels in the cell. To facilitate detection,
these proteins were overexpressed. In the case of Apg1p, this
may have resulted in the saturation of an Apg1p membrane
binding site(s), resulting in the observed soluble pool. Alterna-
tively, Apg1p may cycle between pools both on and off the
membrane. The localization of Apg13p and Apg1p to the P13
fraction is consistent with their localization to either the vac-
uole, a forming Cvt vesicle, or possibly the PVC.
In our current model (Fig. 8), Apg13p and Vac8p may be part
of a larger protein complex that includes Apg1p, and Cvt9p,
and may include additional proteins; recently, Apg17p was
found to interact with Apg1p.2 Apg13p, Vac8p, Apg1p (28), and
Cvt9p are all phosphorylated proteins, and the level of Apg13p
phosphorylation is regulated by the availability of nitrogen.
Apg13p and Vac8p are found in a protein complex in rich media
as well as in the presence of rapamycin (Fig. 2). Apg13p and
Apg1p interact more tightly in starvation conditions when
Apg13p is in the lower phosphorylation state.2 The change in
the level of Apg13p phosphorylation may allow additional
Apg1p and associated proteins such as Cvt9p to be recruited to
the Apg13p/Vac8p complex. This event may, in turn, be in-
volved in switching from the Cvt pathway to autophagy.
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